TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: lactate-to-pyruvate ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: apparent conversion rate constant kPB
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: bicarbonate-to-pyruvate ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Need for intubation
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Need for hospital
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Performance of Hanita Lenses Intensity SL IOL
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Difference in sensitivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Difference in specificity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Concentration of omega-3 fatty acids detectable in Schirmer's tear strips
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of nAUC of tear fluid metabolics from baseline to follow-up visit
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Barry-Albright Dystonia Scale (BADS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Partial arterial tension of oxygen (PaO2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Serum interleukins (IL)-6
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Reduction of Headache Frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peak plasma concentration of rifampicin, isoniazid, pyrazinamide, and ethambutol
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Minimum plasma concentration of rifampicin, isoniazid, pyrazinamide, and ethambutol
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Curve plasma concentration of rifampicin, isoniazid, pyrazinamide, and ethambutol
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sound Quality Rating
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Pain Self Efficacy
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change from Baseline in Short-Form Mcgill Pain questionnaire (SF-MPQ)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from Baseline in Disabilities of the Arm, Shoulder, and Hand (QuickDASH)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in inability to belch
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Purdue Pegboard Test results
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants with Clinically Significant Change From Baseline in Physical Examination Findings
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants with Clinical Laboratory Abnormalities
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proprioceptive sensitivity Assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Nottingham Extended Activities of Daily Living Scale (NEADL)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Sleep Consistency
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Value of questionnaires in screening programme
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Mortality rate of TBI patients
Endpoint domain: Mortality/survival
Primary endpoint: Cost-effectiveness (Quality of life)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Health impairment and quality of life of patients
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Shear wave liver elastography
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number, percentage, and severity of solicited local and systemic reactogenicity AEs
Endpoint domain: Adverse events/effects
Primary endpoint: Number, percentage, and severity of unsolicited AEs
Endpoint domain: Adverse events/effects
Primary endpoint: Number, percentage, and severity of treatment-related AEs
Endpoint domain: Adverse events/effects
Primary endpoint: Maximum voluntary isometric contraction of the knee extensors
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Muscle Fatigue Index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Capillary glucose area under the curve
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Serum Low-Density Lipoprotein cholesterol area under the curve
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Serum High-Density Lipoprotein cholesterol area under the curve
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Serum total cholesterol area under the curve
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Serum triglycerides area under the curve
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: 6-month change in glycosylated hemoglobin level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Feasibility of lifestyle change
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Reduction of functional disability
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Unscheduled readmission
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Electroencephalography (spectral analysis)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Electroencephalography (event related potentials)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in Likelihood of Child's Racial Bias
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in Concern about Children's Racial Bias
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Motivation to Regulate Children's Bias
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Concentration of glucose, insulin and glucagon in plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Incidence, nature, and severity of adverse events graded according to NCI CTCAE v5.0
Endpoint domain: Adverse events/effects
Primary endpoint: Total exposure (area under the curve) from time 0 to the last measurable concentration (AUC0-last)
Endpoint domain: Physiological/clinical
Primary endpoint: Hepatic fat fraction indicators
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Composite endpoint of stroke, myocardial infarction, thromboembolic event or all-cause death
Endpoint domain: Mortality/survival
Primary endpoint: Change in coronary plaque volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Cumulative Excretion Rate of Total Radioactivity in Urine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cumulative Excretion Rate of Total Radioactivity in Feces
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: OAB-V8 score > 8
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in alkaline phosphatase (ALP) levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Peak symptoms related to inoculation with a GMP-adherent influenza A (H3N2) virus
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average duration of symptoms related to inoculation with a GMP-adherent influenza A (H3N2) virus
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peak symptoms related to inoculation with LAIV
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average duration of symptoms related to inoculation with LAIV
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity of Ankle Doppler Waveform Assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Drug Induced Hepatitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: Program Effectiveness Measure in Percentage
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Program Cost-Effectiveness Measured by Number of U.S Dollars
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Program Cost-Effectiveness Measured by Quality Adjusted Life Years
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: time to first intolerant event
Endpoint domain: Adverse events/effects
Primary endpoint: change in CD4%
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: change in BMD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prediction of migraine attacks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Opioid consumption in the first 24 hours
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Worst pain in the first 24 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in subjective pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hypopharyngeal pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: improvement of homocysteine levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: improvement of methionine levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Participants with an Adverse Event (AE)
Endpoint domain: Adverse events/effects
Primary endpoint: Participants who discontinued from study due to an AE
Endpoint domain: Adverse events/effects
Primary endpoint: Maintenance of Wakefulness Test (MWT) for MK-6552
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lipidomic analysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Metabolomic analysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Measurement of Transepidermal Water Loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Plaque and bleeding score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Post-traumatic Stress Disorder
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Relative expression level of SIRT3 mRNA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Flap dehiscence
Endpoint domain: Adverse events/effects
Primary endpoint: fecal calprotectin levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: fecal immunochemical test for hemoglobin results
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: endoscopic scores from colonoscopy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Local and systemic unsolicited reactogenicity adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Any serious adverse events occurring during the study
Endpoint domain: Adverse events/effects
Primary endpoint: Major molecular response (MMR) rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pelvic pain impact
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Kinematic response to stimulus
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Latency of response to stimulus
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Neural response to stimulus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Cut-off value of antral cross-sectional area for empty antrum
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Target Lesion Primary Patency Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Boston Bowel Preparation Scale score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Overall organ preservation rate
Endpoint domain: Mortality/survival
Primary endpoint: Local tumor regrowth rate
Endpoint domain: Mortality/survival
Primary endpoint: Time to surgery or death
Endpoint domain: Mortality/survival
Primary endpoint: Feasibility (no. enrolled)
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Rate of post-randomization exclusions
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Overall response rate (ORR) per RECIST 1.1
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Area under the plasma concentration versus time curve (AUC0-48h)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants with a Surgical Site Infection (SSI)
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of Participants with Treatment-Related Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Pain score VAS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fugl-Meyer Assessment Upper Extremity Scale (FAM-UE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Blood insulin level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Number of Participants with recovery
Endpoint domain: Mortality/survival
Primary endpoint: Number of Participants with Death
Endpoint domain: Mortality/survival
Primary endpoint: Predict response to therapy after induction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Predict sustained response to therapy at 12 Months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Composite remission rate (CRc)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Impact of deploying the tech package within the BCBA workflow
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: INFERTILITY STRESS SCALE score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Epstein Barr virus (EBV) viral load
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Number of participants who complete study participation
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Number of participants who complete post-intervention assessment
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Participants' satisfaction with treatment
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Accuracy of guided surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: EEG changes pre- to post-FUS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reaction time on Psychomotor vigilance task
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients achieving significant change in blood MTX levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Modifiable Cancer Risk Factors
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Change in Suicidal ideation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Suicidal behavior
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Suicides
Endpoint domain: Mortality/survival
Primary endpoint: Change in quadriceps phosphocreatine concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Proportion of Full-dose Self-administered Injections
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Adverse ocular events
Endpoint domain: Adverse events/effects
Primary endpoint: Primary patency of the HAV after implantation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Physiological parameters of the premature infant: peak heart rate (BPM)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Physiological parameters of the premature infant: oxygen saturation (%)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Physiological parameters of the premature infant: body temperature (°C)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Physiological parameters of the premature infant: Respiration rate (RPM)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: absolute mean heart radiation dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Solicited local & Systemic AEs
Endpoint domain: Adverse events/effects
Primary endpoint: Haemoglobin blood levels measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Alkaline Phosphate Blood levels measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Textbook Outcome in Liver Surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Number of Data Collection completed
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of Data points collected containing a variety of exposed spine anatomy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient diversity in Ethnicity
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Patient diversity in Age
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: diagnosis specificity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: diagnosis sensitivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Differential characteristics
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Numerical Rate Score (NRS) for pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intrarater reliability of 3D foot scans
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Interrater reliability of 3D foot scans
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Landing Error Scoring System (LESS) Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Errors rate of Inhaler steps
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: tumor cfDNA as a dynamic marker of response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Mental Clarity
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Gaze holding task
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Visual search task
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Visually guided saccade task
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: PSS-10
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: EDEQ-score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Agreement in energy and nutrient reporting
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of deaths at one-year follow-up
Endpoint domain: Mortality/survival
Primary endpoint: Acceptable Hemodynamic Performance at 30 days
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Incidence, severity, and outcome of treatment emergent adverse events (TEAEs) and serious adverse events (SAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of colonoscopies with adequate preparation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of children's nighttime scratching episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Duration of children's nighttime scratching episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Scratch assessment by adult caregiver
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Rate of participating patients from whom a urine sample can be obtained
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Rate of urine samples from which a valid result can be obtained
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Average time needed by study personnel to complete study procedures
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Respiratory functions (PEF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes